Insider Transactions
| Date | Name | Title | Type | Filing | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Feb 28, 2008 | Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 500 | $10.05 | 758,781 | |
| Feb 28, 2008 | Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 500 | $9.85 | 751,581 | |
| Feb 28, 2008 | Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 500 | $9.96 | 753,019 | |
| Feb 28, 2008 | Senior VP, Drug Development | Open market or private sale of non-derivative or derivative security | Form 4 | 500 | $10.46 | 45,366 | |
| Feb 28, 2008 | Director, Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 500 | $9.85 | 751,581 | |
| Feb 28, 2008 | Director, Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 500 | $9.96 | 753,019 | |
| Feb 28, 2008 | Director, Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 500 | $10.05 | 758,781 | |
| Feb 27, 2008 | Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 500 | $9.70 | 730,481 | |
| Feb 27, 2008 | Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 500 | $9.71 | 730,981 | |
| Feb 27, 2008 | Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 500 | $9.98 | 743,381 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.